Mikel Ross on Patient Tolerability of Cooling Caps for Chemotherapy-Induced Hair Loss

Video

Mikel Ross discusses the cooling cap intervention for chemotherapy-induced hair loss and patients' tolerability.

Mikel Ross, BSN, RN, OCN, from Memorial Sloan Kettering Cancer Center, discusses the cooling cap intervention for chemotherapy-induced hair loss and how patients tolerated the treatment.

Patients seem to tolerate this intervention well. However, it does add time to the chemotherapy process, as a pre-cooling and post-cooling period is required. This time commitment is likely the main reason for discontinuation. Otherwise, there only seems to be a cold sensation that patients have reported.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.